PIRAMAL PHARMA
Back to Balance Sheet
|
PIRAMAL PHARMA Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-145 Cr | ₹-157 Cr | ₹-130 Cr | ₹-105 Cr | ₹-22 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of PIRAMAL PHARMA ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-145 Cr |
| Mar2024 | ₹-157 Cr |
| Mar2023 | ₹-130 Cr |
| Mar2022 | ₹-105 Cr |
| Mar2021 | ₹-22 Cr |
How is Deferred Tax Assets / Liabilities of PIRAMAL PHARMA Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-145 Cr | Negative | |
| Mar2024 | ₹-157 Cr | Negative | |
| Mar2023 | ₹-130 Cr | Negative | |
| Mar2022 | ₹-105 Cr | Negative | |
| Mar2021 | ₹-22 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of PIRAMAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PIRAMAL PHARMA | ₹23,001.8 Cr | -5% | -11.4% | -36.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,170.0 Cr | -1.6% | 4.6% | -0.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,038.0 Cr | -2.5% | -6% | 3.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹127,357.0 Cr | 1.2% | -1.4% | 11.8% | Stock Analytics | |
| CIPLA | ₹120,414.0 Cr | -1.2% | -1.5% | -0.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,015.0 Cr | -2.7% | 4% | 2.2% | Stock Analytics | |
PIRAMAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PIRAMAL PHARMA | -5% |
-11.4% |
-36.3% |
| SENSEX | -0.6% |
1.7% |
4.6% |
You may also like the below Video Courses